SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-A12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001144204-18-032024
Filing Date
2018-05-31
Accepted
2018-05-31 16:56:46
Documents
14

Document Format Files

Seq Description Document Type Size
1 8-A12B tv495581_8a12b.htm 8-A12B 16247
2 EXHIBIT 3.1 tv495581_ex3-1.htm EX-3.1 5230
3 EXHIBIT 3.2 tv495581_ex3-2.htm EX-3.2 39805
4 EXHIBIT 4.1 tv495581_ex4-1.htm EX-4.1 454495
5 EXHIBIT 4.2 tv495581_ex4-2.htm EX-4.2 134761
6 GRAPHIC image_001.jpg GRAPHIC 78765
7 GRAPHIC image_003.jpg GRAPHIC 77921
8 GRAPHIC image_009.jpg GRAPHIC 74494
9 GRAPHIC image_004.jpg GRAPHIC 120627
10 GRAPHIC image_005.jpg GRAPHIC 30494
11 GRAPHIC image_006.jpg GRAPHIC 73784
12 GRAPHIC image_007.jpg GRAPHIC 18153
13 GRAPHIC image_008.jpg GRAPHIC 31853
14 GRAPHIC image_010.jpg GRAPHIC 2656
  Complete submission text file 0001144204-18-032024.txt   1353123
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-A12B | Act: 34 | File No.: 001-38512 | Film No.: 18872340
SIC: 2834 Pharmaceutical Preparations